Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC
- Status
- UNKNOWN
- Phase
- PHASE2
PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy
- Status
- UNKNOWN
- Phase
- NA
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- Status
- COMPLETED
- Phase
- PHASE1
TS Overexpression in SCLC: Mechanism and Therapeutic Targeting
- Status
- COMPLETED
- Phase
- N/A
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Expanded Access to Rovalpituzumab Tesirine
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain
- Status
- TERMINATED
- Phase
- NA
Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1